Ranbaxy launches isotretinoin product in U.S.

Article

Ranbaxy is launching its isotretinoin product for the treatment of acne, Absorica, in the United States.

Related Videos
Related Content

Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD

October 1st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Derm In The News: September 24-30

September 30th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis

September 30th 2023

Evaluating Efficacy of Trifarotene in Latin American Patients With Acne

September 30th 2023

Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD

October 1st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Derm In The News: September 24-30

September 30th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis

September 30th 2023

Evaluating Efficacy of Trifarotene in Latin American Patients With Acne

September 30th 2023

Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD

October 1st 2023

The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis

June 12th 2023

Derm In The News: September 24-30

September 30th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis

September 30th 2023

Evaluating Efficacy of Trifarotene in Latin American Patients With Acne

September 30th 2023
© 2023 MJH Life Sciences

All rights reserved.